{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:30:13Z","timestamp":1760239813087,"version":"build-2065373602"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T00:00:00Z","timestamp":1609027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Recent data suggests that herpes zoster (HZ) and herpes simplex virus (HSV) may be one of the underlying immunological triggers for giant cell arteritis (GCA). However, there is limited population-based data to support this. Our goal was to determine if herpetic infections increase the likelihood of GCA in the British Columbia (BC) population. The background prevalence of GCA was compared to the prevalence of GCA in subjects with HZ and HSV using diagnostic billing code data from an online BC database (BC Data ScoutTM). BC residents \u226530 years old at the time of diagnosis from January 2000 to January 2019 were included. The relevant International Classification of Disease codes was used to identify patients with GCA, HZ, and HSV. Comparisons were made using two-sample Z tests. There were 4315 GCA diagnoses, from a total population of 3,026,005 subjects. The prevalence of GCA was 143 per 100,000 people. In terms of herpetic infections, 850 GCA cases were identified in 249,900 subjects with HZ versus 310 diagnoses of GCA in 163,170 subjects with HSV. The prevalence of GCA in subjects with HZ (0.340%) was significantly higher than the prevalence of GCA (0.143%) in the general population (p &lt; 0.00001). The prevalence of GCA in HSV subjects (0.190%) was also significantly higher (p &lt; 0.00001) than the population prevalence but lower than (p &lt; 0.00001) the GCA with HZ prevalence. The likelihood of GCA appears to increase with herpetic infections, more significantly with HZ.<\/jats:p>","DOI":"10.3390\/jcm10010063","type":"journal-article","created":{"date-parts":[[2020,12,27]],"date-time":"2020-12-27T20:04:58Z","timestamp":1609099498000},"page":"63","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Is There an Association between Herpetic Infections and Giant Cell Arteritis? A Population-Based Study"],"prefix":"10.3390","volume":"10","author":[{"given":"Dong-ho","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC V5Z 3N9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Iovieno","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC V5Z 3N9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire A.","family":"Sheldon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC V5Z 3N9, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"A544","DOI":"10.1016\/j.autrev.2012.01.003","article-title":"Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment","volume":"11","author":"Borchers","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.autrev.2017.05.014","article-title":"Recent advances in our understanding of giant cell arteritis pathogenesis","volume":"16","author":"Samson","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.autrev.2010.05.002","article-title":"Pathogenesis of giant cell arteritis: More than just an inflammatory condition?","volume":"9","author":"Ly","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000292","article-title":"Varicella zoster virus triggers the immunopathology of giant cell arteritis","volume":"28","author":"Gilden","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1212\/NXI.0000000000000216","article-title":"VZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteries","volume":"3","author":"Gilden","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1309\/2996TT2CTLTKN0KT","article-title":"High prevalence of herpes simplex virus DNA in temporal arteritis biopsy specimens","volume":"123","author":"Powers","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajo.2017.12.017","article-title":"Identification of Herpes Zoster\u2013Associated Temporal Arteritis Among Cases of Giant Cell Arteritis","volume":"187","author":"Buckingham","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-510X(03)00167-9","article-title":"Absence of detection of Varicella-Zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis","volume":"215","author":"Kennedy","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.21092","article-title":"Infection and temporal arteritis: A PCR-based study to detect pathogens in temporal artery biopsy specimens","volume":"80","author":"Cooper","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2004.025320","article-title":"Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: Analysis with quantitative real time polymerase chain reaction","volume":"64","author":"Jover","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2004.05.003","article-title":"No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis","volume":"31","author":"Stone","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/rheumatology\/kez556","article-title":"Assessment for varicella zoster virus in patients newly suspected of having giant cell arteritis","volume":"59","author":"Sammel","year":"2019","journal-title":"Rheumatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/annrheumdis-2016-210152","article-title":"Infections and the risk of incident giant cell arteritis: A population-based, case-control study","volume":"76","author":"Rhee","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/art.40236","article-title":"Herpes Zoster as a Risk Factor for Incident Giant Cell Arteritis","volume":"69","author":"England","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12016-008-8075-0","article-title":"The Geo-epidemiology of Temporal (Giant Cell) Arteritis","volume":"35","author":"Lee","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_17","unstructured":"British Columbia Ministry of Health, Population Data BC and BC Support Unit (2018). BC DataScoutTM. Version 1, Population Data BC."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: A systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Koster, M.J., and Warrington, K.J. (2017). Giant cell arteritis: Pathogenic mechanisms and new potential therapeutic targets. BMC Rheumatol., 1.","DOI":"10.1186\/s41927-017-0004-5"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2017.01377","article-title":"Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis","volume":"8","author":"Rondaan","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.40363","article-title":"Varicella Zoster Virus-Specific T Cell Responses in Untreated Giant Cell Arteritis: Comment on the Article by England et al","volume":"70","author":"Bigler","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_22","first-page":"295","article-title":"Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998\u20132003","volume":"42","author":"Ramstead","year":"2007","journal-title":"Can. J. Ophthalmol."},{"key":"ref_23","unstructured":"Statistics Canada (2019, December 16). British Columbia and Canada (Table). Census Profile. 2016 Census. Statistics Canada Catalogue no. 98-316-X2016001, Available online: https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/dp-pd\/prof\/index.cfm?Lang=E."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2796.1990.tb00150.x","article-title":"Epidemiology of biopsy-proven giant cell arteritis (GCA)","volume":"227","author":"Nordborg","year":"1990","journal-title":"J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.30.3.224","article-title":"Temporal arteritis in a large necropsy series","volume":"30","author":"Ostberg","year":"1971","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/kex173","article-title":"The use of ultrasound to assess giant cell arteritis: Review of the current evidence and practical guide for the rheumatologist","volume":"57","author":"Monti","year":"2018","journal-title":"Rheumatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/jmv.21599","article-title":"Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture","volume":"81","author":"Toyama","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3122\/jabfm.2013.01.120154","article-title":"Herpes Zoster Knowledge, Prevalence, and Vaccination Rate by Race","volume":"26","author":"Lee","year":"2013","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/infdis\/171.3.701","article-title":"Racial Differences in the Occurrence of Herpes Zoster","volume":"171","author":"Schmader","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1090-3801(99)90015-0","article-title":"The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population","volume":"3","author":"Bowsher","year":"1999","journal-title":"Eur. J. Pain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/sti.78.3.201","article-title":"Seroprevalence of HSV-1 and HSV-2 infection in the general French population","volume":"78","author":"Malkin","year":"2002","journal-title":"Sex. Transm. Infect."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","article-title":"Herpes Simplex Virus Type 2 in the United States, 1976 to 1994","volume":"337","author":"Fleming","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/JCM.41.1.84-89.2003","article-title":"Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada","volume":"41","author":"Howard","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_34","unstructured":"McQuillan, G., Kruszon-Moran, D., Flagg, E.W., and Paulose-Ram, R. (2018). Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14\u201349: United States 2015\u20132016."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Looker, K.J., Magaret, A.S., Turner, K.M.E., Vickerman, P., Gottlieb, S.L., and Newman, L.M. (2015). Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128615"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (2007). Persistence in the Population: Epidemiology, Transmission. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press.","DOI":"10.1017\/CBO9780511545313"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/1\/63\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:46:34Z","timestamp":1760179594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/1\/63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["jcm10010063"],"URL":"https:\/\/doi.org\/10.3390\/jcm10010063","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2020,12,27]]}}}